Ga naar de inhoud
PodcastsGeschiedenisWorks in Progress Podcast

Works in Progress Podcast

Works in Progress
Works in Progress Podcast
Nieuwste aflevering

43 afleveringen

  • Works in Progress Podcast

    Are miracle drugs hiding in plain sight?

    24-07-2026 | 2 u. 32 Min.
    ** We’ve paused the Works in Progress podcast feed, so head over to our dedicated Hard Drugs podcast feed to listen to future episodes, if you hadn’t subscribed there already! https://harddrugs.worksinprogress.co/ **
    GLP-1 drugs like Ozempic and Mounjaro have transformed the treatment of obesity as well as diabetes, can help treat heart disease, kidney disease, sleep apnea, and maybe even Alzheimer’s. But they are far from the only medicine with more than one use. Aspirin, colchicine, minoxidil, and Viagra were all found to treat more conditions than expected, and about a third of drugs end up with a second approved use.
    In this episode, Jacob and Saloni explore the idea of drug repurposing: taking a medicine made for one disease and finding it works against others. They trace how GLP-1 drugs emerged from an adorable Gila monster, why some drugs have multiple uses, why so many of those uses go untested, and how patents, competition, prizes, and platform trials shape whether we ever find them.

    Hard Drugs is a podcast from Works in Progress about medical innovation presented by Saloni Dattani and Jacob Trefethen.

    You can watch or listen on YouTube, Spotify, or Apple Podcasts.
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/
    Jacob’s blog: https://blog.jacobtrefethen.com/ 
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer
    Blogs
    Julia Rohrer (2018). The uncanny mountain: p-values between .01 and .10 are still a problem https://www.the100.ci/2018/02/15/the-uncanny-mountain-p-values-between-01-and-10-are-still-a-problem/ 
    Abhishaike Mahajan (2025). Mapping the off-target effects of every FDA-approved drug in existence (EvE Bio) https://www.owlposting.com/p/mapping-the-off-target-effects-of 
    Videos
    George Davey Smith (2026). Does the shingles vaccine prevent dementia? https://www.youtube.com/watch?v=qlTnnQytOJ0 
    Articles & report
    Radwan Darwish et al. (2025). History of glucagon-like peptide-1 receptor agonists. https://doi.org/10.1016/j.phrs.2025.108045 
    Brian L. Furman (2012). The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. https://doi.org/10.1016/j.toxicon.2010.12.016 
    Eric Budish, Maya M. Durvasula, Benjamin N. Roin, Heidi L. Williams (2026). Missing markets for innovation: evidence from new uses for existing drugs. NBER Working paper. https://www.nber.org/system/files/working_papers/w34222/w34222.pdf 
    Babak Sahragardjoonegani, Reed F Beall, Aaron S Kesselheim, Aidan Hollis (2021). Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997. https://pmc.ncbi.nlm.nih.gov/articles/PMC7780607/ 
    BMJ (2020). Covid-19: The inside story of the RECOVERY trial https://www.bmj.com/content/370/bmj.m2670 
    Stephan Guyenet (2021). The future of weight loss https://worksinprogress.co/issue/the-future-of-weight-loss/ 
    Kevin Hickey, Erin Ward (2024). The Role of Patents and Regulatory Exclusivities in Drug Pricing https://www.congress.gov/crs-product/R46679 
    Alex Kesin (2025). The three-thousand-year journey of colchicine https://worksinprogress.co/issue/the-three-thousand-year-journey-of-colchicine/ 
    Samy Suissa, Laurent Azoulay (2012). Metformin and the risk of cancer: time-related biases in observational studies https://doi.org/10.2337/dc12-0788 
    Nicholas Reville (2026). Proposing an NIH High-Leverage Trials (HILT) Program. Center for Addiction Science, Policy, and Research (CASPR) https://caspr.org/policy/papers/HILT/ 
    Web
    Smithsonian’s National Zoo. Gila monster. https://nationalzoo.si.edu/animals/gila-monster
  • Works in Progress Podcast

    Issue 24: Rats, The Glorious Revolution and the secret to ultra-Orthodox fertility

    17-06-2026 | 1 u.
    Alberta is the only part of the world that has people but not rats. Rats came to the new world on ships to New York, Boston and Philadelphia during the Industrial Revolution. From there they spread west at a rate of 24 kilometers a year and by 1950 they were on Alberta's border. But Albertans stopped them coming any further.
    In the US there is a culture that lives in dense cities, the women usually work, and yet they still have an average of six children each. The ultra-Orthodox have a number of pro-fertility norms, most of which wouldn't work for the secular world but some we could learn from.
    Sam, Pieter, and Aria discuss a handful of pieces in Issue 24 of Works in Progress. They talk land reclamation, vaccinating wild animals, the Squamish Nation's housing development in Vancouver and how The Glorious Revolution caused the Industrial Revolution.
    Buy your copy here: https://worksinprogress.co/print/
  • Works in Progress Podcast

    The lost art of building cities

    03-06-2026 | 1 u. 25 Min.
    In the nineteenth century, cities often grew a thousandfold while increasing wages, the size of homes, and delivering great public goods like electricity and plumbing to their people. What made them so extraordinary? They had a hybrid of laissez-faire and top-down control. Landowners could build almost anything they liked but street networks were laid out with near-Soviet thoroughness decades in advance. Transport and utilities, meanwhile, ran as regulated monopolies. They were funded by users, turned a profit, but prices were controlled.
    Samuel, Ben and Aria discuss what made this system work and why it was dismantled.
  • Works in Progress Podcast

    Inventing the second malaria vaccine with Katharine Collins

    27-05-2026 | 2 u. 15 Min.
    Malaria is caused not by a virus or bacterium, but by a complex, shape-shifting parasite that has evolved alongside us for millennia. This has made vaccine development a brutal challenge.
    In this episode, Jacob and Saloni are joined by Katharine Collins, who co-invented the second malaria vaccine, called R21, during her PhD. They discuss the gruelling process of reverse-engineering a vaccine and eureka moments along the way. They ask whether the biggest barriers to new vaccines are scientific or financial, and what it will take to finally eradicate one of natureʼs most vicious killers.
    Hard Drugs is a podcast from Works in Progress about medical innovation presented by Saloni Dattani and Jacob Trefethen.
    You can watch or listen on YouTube, Spotify, or Apple Podcasts.
    Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

    Jacob’s blog: https://blog.jacobtrefethen.com/ 
    Acknowledgements:
    Aria Babu, editor at Works in Progress
    Graham Bessellieu, video editor
    Alice Edwards, captions
    Abhishaike Mahajan, cover art
    Atalanta Arden-Miller, art direction
    David Hackett, composer

    Works in Progress & Coefficient Giving 
    Thesis
    Katharine Collins (2014). R21, a novel particle based vaccine for a multi-component approach to malaria vaccination.

    Books
    R. Killick-Kendrick (2012). Rodent Malaria.
    Michael Kremer and Rachel Glennerster (2004). Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.

    Articles and reports
    Saloni Dattani (2023). Why we didn’t get a malaria vaccine sooner. https://worksinprogress.co/issue/why-we-didnt-get-a-malaria-vaccine-sooner/ 
    Jerome P Vanderberg (2010). Reflections on Early Malaria Vaccine Studies, the First Successful Human Malaria Vaccination, and Beyond https://pmc.ncbi.nlm.nih.gov/articles/PMC2637529/
    Pratik Pawar (2022). It Took 35 years to Get a Malaria Vaccine. Why? https://undark.org/2022/05/25/it-took-35-years-to-get-a-malaria-vaccine-why/ 
    Ernst R. Berndt, Rachel Glennerster, Michael R. Kremer, Jean Lee, Ruth Levine, Georg Weizsacker & Heidi Williams (2005) Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness. https://www.nber.org/papers/w11288 
    Ryan Duncombe, Karam Elabd and Justin Sandefur (2024). Avoiding Another Lost Decade on Malaria Vaccines https://www.cgdev.org/publication/avoiding-another-lost-decade-malaria-vaccines
  • Works in Progress Podcast

    Where did all the good sculptors go?

    20-05-2026 | 1 u. 19 Min.
    The Trump administration wants to bolster traditional art. Their attempt to revive sculpture, a mass statue-building program, is doomed. America doesn’t have the sculptors, foundries, and workers to make hundreds of bronze or marble sculptures. North Korea would be in a much better position.
    Sam and Samuel sit down with our Art Director, Atalanta, a sculptor by training, and talk all things sculpture. They discuss how art education has become de-skilled, how sculpture has always been the best art form for mass production and the surprising places the tradition has been kept alive.
Meer Geschiedenis podcasts
Over Works in Progress Podcast
Works in Progress is an online magazine devoted to new and underrated ideas about economic growth, scientific progress, and technology. Subscribe to listen to the Works in Progress podcast, plus Hard Drugs by Saloni Dattani and Jacob Trefethen.
Podcast website

Luister naar Works in Progress Podcast, Verraad in de geschiedenis en vele andere podcasts van over de hele wereld met de radio.net-app

Ontvang de gratis radio.net app

  • Zenders en podcasts om te bookmarken
  • Streamen via Wi-Fi of Bluetooth
  • Ondersteunt Carplay & Android Auto
  • Veel andere app-functies
Works in Progress Podcast: Podcasts in familie